MarginsXMarginsX
Home › Markets › Health Care › COLL

Collegium Pharmaceutical Inc. (COLL)

COLL trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$25.43
+0.43% on the day
Market cap
$790.2M
Small cap
Revenue · 2025
$780.6M
+23.6% on 2024
Net income · 2025
$62.9M
8.1% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1267565/000162828026011992/0001628280-26-011992-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCOLL on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2015
SEC CIK0001267565
SEC industry codePharmaceutical Preparations
Incorporated inVA

Financials · 2025

LineValue
Revenue$780.6M
Net income$62.9M
Operating income$179.6M
Net margin8.1%
Operating margin23.0%
Revenue growth+23.6%
Cash$231.3M
Total assets$1.7B
P/E (computed)12.6×
P/S (computed)1.0×

Warning signs

Cash runway
Cash-flow positive
$144.8M cash at September 30, 2026
Share count, 1 year
-1.7%
2025-10-31 to 2026-10-31 · -4.7% over 3 years
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
-$7.2M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$144.8M cash; operating cash flow $84.5M a quarter.Report 2026-09-30
Shares outstanding31,075,424 (2026-10-31); 31,610,976 a year earlier; 32,610,873 three years earlier.Cover page 2026-10-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorDeloitte & Touche LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-04
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $7.2M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$216.3M$21.8M$86.5M$144.8M$60.5M$815.2M10-Q 2026-11-05
Q2 2026
2026-06-30
$199.9M-$15.1M$71.3M$129.5M$55.0M$808.2M10-Q 2026-08-06
Q1 2026
2026-03-31
$193.5M$14.5M$57.1M$268.6M$32.6M$796.3M10-Q 2026-05-07
Q4 2025
2025-12-31
$205.4M$17.0M$123.0M$231.3M$29.0M$780.6M10-K 2026-02-26
Q3 2025
2025-09-30
$209.4M$31.5M$78.4M$150.1M$64.6M$757.1M10-Q 2026-11-05
Q2 2025
2025-06-30
$188.0M$12.0M$72.4M$117.3M$64.6M$707.0M10-Q 2026-08-06
Q1 2025
2025-03-31
$177.8M$2.4M$55.4M$96.2M$64.6M$664.3M10-Q 2026-05-07
Q4 2024
2024-12-31
$181.9M$12.5M$84.6M$70.6M$64.6M$631.4M10-K 2026-02-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-32020-03-16
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxyDEF 14A2026-04-07

Source: SEC EDGAR submissions feed, 875 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+4.6%
1 month+17.6%
3 months-10.1%
Year to date-45.3%
1 year-45.4%
From 52-week high-49.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
IVAInventiva S.A. American Depository Shares$3.32-9.78%$784.5M
ORICOric Pharmaceuticals Inc.$7.52-4.33%$779.5M
LXRXLexicon Pharmaceuticals Inc.$1.75-2.23%$779.2M
IRWDIronwood Pharmaceuticals Inc.$4.85+0.41%$802.9M
ARDXArdelyx Inc.$3.07-0.65%$771.7M
OBXObsidian Therapeutics Inc.$12.36-1.59%$763.5M
SNDXSyndax Pharmaceuticals Inc.$9.13-3.39%$821.6M
RIGLRigel Pharmaceuticals Inc.$43.73-1.64%$823.4M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier